Marquez-Megias, S., Ramon-Lopez, A., Más-Serrano, P., Diaz-Gonzalez, M., Candela-Boix, M. R., & nalda-molina, R. (2021). Evaluation of the Predictive Performance of Population Pharmacokinetic Models of Adalimumab in Patients with Inflammatory Bowel Disease.
Citación estilo ChicagoMarquez-Megias, Silvia, Amelia Ramon-Lopez, Patricio Más-Serrano, Marcos Diaz-Gonzalez, Maria Remedios Candela-Boix, y Ricardo nalda-molina. Evaluation of the Predictive Performance of Population Pharmacokinetic Models of Adalimumab in Patients With Inflammatory Bowel Disease. 2021.
Cita MLAMarquez-Megias, Silvia, et al. Evaluation of the Predictive Performance of Population Pharmacokinetic Models of Adalimumab in Patients With Inflammatory Bowel Disease. 2021.